| Description |
1 online resource |
| Contents |
Hepatitis C virus / Ahmed Abdel Aziz -- Epidemiology and modes of transmission of HCV in developing countries / Sanaa M. Kamal and Dahlia Ghoraba -- Public health and economic burden of Hepatitis C infection in developing countries / Tamer A. Hafez -- Social, cultural, and political factors influencing HCV in developing countries / Sara A. Abdelhakam and Mohamad A. Othman -- Hepatitis C in Egypt / Sanaa M. Kamal and Sara A. Abdelhakam -- Hepatitis C in North Africa (Arabic Maghreb region) / Mohamed A. Daw -- Hepatitis C virus in sub-saharan Africa / Osi Obadahn and Sanaa M. Kamal -- Hepatitis C virus infection in the Indian sub-continent / Shashi Shekhar -- Hepatitis C in developing countries in southeast Asia / Thi Q. Doan -- Hepatitis C and schistosomisasis coinfection / Sanaa M. Kamal -- Hepatitis C and Helminthic infections / Khalifa S. Khalifa and Othman Amin -- Hepatitis C and HIV coinfection in developing countries / Ozlem Tastan Bishop -- Hepatiis B and C coinfection / Georgios Zacharakis -- Hepatitis C infection in patients with hemogloinopathies / Sanaa M. Kamal and Ahmed M. Fouad -- Hepatitis C in patients on hemodialysis / Tamer A. Hafez -- Hepatitis C screening and diagnosis in developing countries / Huda H. Gaafar -- Hepatitis C treatment in the era of direct-acting antiviral agents / Sanaa M. Kamal |
| Summary |
"Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1. Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinomaPresents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C"-- Provided by publisher |
| Notes |
Online resource; title from PDF title page (EBSCO, viewed November 30, 2017) |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Hepatitis C -- Developing countries
|
|
Hepatitis C.
|
|
Hepatitis C virus.
|
|
Hepatitis C
|
|
Developing Countries
|
|
Hepacivirus
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Hepatitis C virus
|
|
Hepatitis C
|
|
Developing countries
|
| Form |
Electronic book
|
| Author |
Kamal, Sanaa M., editor
|
| ISBN |
9780128032343 |
|
0128032340 |
|
